A 28-patient phase 1 gene therapy clinical trial for the degenerative retinal disease Leber hereditary optic neuropathy (LHON) found no significant safety concerns; however, treatment failed to improve or slow vision loss, ...
Jun 2, 2022
0
2
You probably slather on sunscreen to protect your skin, but your eyes need protection from the sun's rays, too.
May 30, 2022
0
3
People with neurofibromatosis type 1 (NF1) develop tumors on nerves throughout their bodies. These tumors are usually benign—meaning they don't spread to other parts of the body and are not considered life-threatening—but ...
May 19, 2022
0
60
A literature review in Harvard Review of Psychiatry indicates that, while transcranial electrical stimulation (tES) has rarely been used in treating visual hallucinations (VH) among patients with psychiatric disorders, ...
May 13, 2022
0
19
When people get into their 40s and beyond, their close-up vision starts to worsen. For many people, cranking up the font size on a phone or maxing out the brightness on a computer is the only way to be able to read some ...
May 6, 2022
0
238
A ubiquitous protein called sigma 1 receptor, which is known to protect cells from stress, appears key to the function and survival of the neurons most impacted by glaucoma, scientists report.
Mar 1, 2022
0
7
Developing therapies for genetic forms of blindness is extremely challenging, in part because they vary so widely, but scientists from Trinity College Dublin have highlighted a target with great promise for treating a range ...
Feb 17, 2022
0
2
The biochemistry of vision is a complex process. The molecules supporting the visual pigments that allow us to see our surrounding reality have remained essentially invisible for scientists for a long time. The team led by ...
Jan 12, 2022
0
4
(HealthDay)—Eat right to protect your sight.
Jan 10, 2022
0
12
January is National Glaucoma Awareness Month, which makes this a good time to learn more about treating this group of eye conditions.
Jan 5, 2022
0
13
